These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through affiliate links at no additional cost to the purchaser.
Wrinkle-reducer Botox now has some competition. Biotech company Revance’s Daxxify injection uses botulinum toxin, similar to Botox, but it’s also powered by peptides, amino acids that make up proteins the skin needs, and studies suggest that its effects last roughly two months longer than Botox. Daxxify has been commercially available since March, and in August, the FDA approved it for another use, which will come to market mid-2024: It can treat cervical dystonia—painful, involuntary neck muscle contractions—relieving symptoms for up to three months longer than the current treatment.
More Must-Reads from TIME
- Eyewitness Accounts From the Trump Rally Shooting
- Politicians Condemn Trump Rally Shooting: ‘No Place for Political Violence in Our Democracy’
- From 2022: How the Threat of Political Violence Is Transforming America
- ‘We’re Living in a Nightmare:’ Inside the Health Crisis of a Texas Bitcoin Town
- Remembering Shannen Doherty, the Quintessential Gen X Girl
- How Often Do You Really Need to Wash Your Sheets?
- Welcome to the Noah Lyles Olympics
- Get Our Paris Olympics Newsletter in Your Inbox